Subscribe to Our Newsletter
OAKLAND – California Attorney General Rob Bonta today announced his conditional approval of the change in control of seven skilled nursing facilities (SNFs) from ProMedica Health System, an Ohio nonprofit corporation to Providence Group, Inc. (Providence Group), a California for-profit corporation. Under California law, any transaction involving the sale or transfer of control of a nonprofit healthcare facility must secure the approval of the Attorney General.
“Our top priority when reviewing healthcare transactions is the safety of the residents,” said Attorney General Bonta. “Due to the strong conditions we’ve imposed, individuals who live in these nursing facilities will continue receiving care in the place they call home. At the Department of Justice, we remain unwavering in our commitment to supporting a long-term care system that ensures high-quality, uninterrupted care for all residents.”
The seven SNFs involved in this transaction are:
The buyer, Providence Group, will begin operating the facilities, assume control of their assets, obligations, and liabilities in exchange of a purchase or sale. Since 2012, the Providence Group has operated in California and is currently responsible for over 10,000 licensed beds and 20,000 employees in the state. An expert analysis, whose expertise includes assessing healthcare impact within skilled nursing facilities, found the transaction would ensure access and quality across all facilities.
As part of his conditional approval, Attorney General Bonta has imposed specific conditions for the transfer which would require Providence Group to, among other things:
The California Department of Justice’s Healthcare Rights and Access Section (HRA) works proactively to increase and protect the affordability, accessibility, and quality of healthcare in California. HRA’s attorneys monitor and contribute to various areas of the Attorney General’s healthcare work, including nonprofit healthcare transactions; consumer rights; anticompetitive consolidation in the healthcare market; anticompetitive drug pricing; privacy issues; civil rights, such as health equity, reproductive rights and LGBTQ healthcare-related rights; and public health work on tobacco, e-cigarettes, and other products.
A copy of the conditional approval letter is available here.